Acutaas Chemicals Share Price
Sector: Chemical Manufacturing
1100.25 -4.20 (-0.38%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1097.65
Today’s High
1132.90
52 Week Low
600.00
52 Week High
1321.75
1102.80 -2.20 (-0.20%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1098.40
Today’s High
1132.50
52 Week Low
607.50
52 Week High
1322.00
Key Metrics
- Market Cap (In Cr) 9007.63
- Beta 0.99
- Div. Yield (%) 0.13
- P/B 7.02
- TTM P/E 61.02
- Sector P/E 26.14
- D/E 0
- Open Price 1105
- Prev Close 1104.45
Acutaas Chemicals Analysis
Price Analysis
-
1 Week-0.73%
-
3 Months1.43%
-
6 Month-0.33%
-
YTD2.85%
-
1 Year75.15%
Risk Meter
- 55% Low risk
- 55% Moderate risk
- 55% Balanced Risk
- 55% High risk
- 55% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 4
- 4
- 2
- 3
- Buy
- 1
- 1
- 1
- 1
- Hold
- 0.00
- 0.00
- 1
- 1
- Sell
- 1
- 1
- 1
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 6
- 6
- 5
- 5
Acutaas Chemicals Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 1006.88
- Selling/ General/ Admin Expenses Total
- 83.66
- Depreciation/ Amortization
- 26.62
- Other Operating Expenses Total
- 138.96
- Total Operating Expense
- 801.42
- Operating Income
- 205.45
- Net Income Before Taxes
- 216.16
- Net Income
- 158.71
- Diluted Normalized EPS
- 19.81
- Period
- 2025
- Total Assets
- 1549.26
- Total Liabilities
- 239.63
- Total Equity
- 1309.63
- Tangible Book Valueper Share Common Eq
- 152.02
- Period
- 2025
- Cashfrom Operating Activities
- 118.34
- Cashfrom Investing Activities
- -223.94
- Cashfrom Financing Activities
- 261.12
- Net Changein Cash
- 155.52
- Period
- 2024
- Total Revenue
- 717.47
- Selling/ General/ Admin Expenses Total
- 88.16
- Depreciation/ Amortization
- 16.06
- Other Operating Expenses Total
- 89.14
- Total Operating Expense
- 637.12
- Operating Income
- 80.35
- Net Income Before Taxes
- 81.9
- Net Income
- 42.77
- Diluted Normalized EPS
- 8.42
- Period
- 2024
- Total Assets
- 1095.9
- Total Liabilities
- 421.91
- Total Equity
- 674
- Tangible Book Valueper Share Common Eq
- 82.28
- Period
- 2024
- Cashfrom Operating Activities
- 125.17
- Cashfrom Investing Activities
- -365.39
- Cashfrom Financing Activities
- 239.36
- Net Changein Cash
- -0.83
- Period
- 2023
- Total Revenue
- 616.73
- Selling/ General/ Admin Expenses Total
- 80.91
- Depreciation/ Amortization
- 12.34
- Other Operating Expenses Total
- 81.58
- Total Operating Expense
- 505.72
- Operating Income
- 111.01
- Net Income Before Taxes
- 112.17
- Net Income
- 83.29
- Diluted Normalized EPS
- 11.51
- Period
- 2023
- Total Assets
- 766.94
- Total Liabilities
- 172.98
- Total Equity
- 593.96
- Tangible Book Valueper Share Common Eq
- 75.82
- Period
- 2023
- Cashfrom Operating Activities
- 65.53
- Cashfrom Investing Activities
- -33.04
- Cashfrom Financing Activities
- -12.25
- Net Changein Cash
- 20.24
- Period
- 2022
- Total Revenue
- 520.14
- Selling/ General/ Admin Expenses Total
- 67.28
- Depreciation/ Amortization
- 10.08
- Other Operating Expenses Total
- 74.84
- Total Operating Expense
- 425.04
- Operating Income
- 95.1
- Net Income Before Taxes
- 91.45
- Net Income
- 71.95
- Diluted Normalized EPS
- 10.52
- Period
- 2022
- Total Assets
- 658.88
- Total Liabilities
- 136.61
- Total Equity
- 522.27
- Tangible Book Valueper Share Common Eq
- 68
- Period
- 2022
- Cashfrom Operating Activities
- -8.66
- Cashfrom Investing Activities
- -123.99
- Cashfrom Financing Activities
- 140.26
- Net Changein Cash
- 7.61
- Period
- 2021
- Total Revenue
- 336.21
- Selling/ General/ Admin Expenses Total
- 26.64
- Depreciation/ Amortization
- 4.19
- Other Operating Expenses Total
- 53.98
- Total Operating Expense
- 264.14
- Operating Income
- 72.07
- Net Income Before Taxes
- 71.73
- Net Income
- 54
- Diluted Normalized EPS
- 7.39
- Period
- 2021
- Total Assets
- 413.27
- Total Liabilities
- 246.33
- Total Equity
- 166.93
- Tangible Book Valueper Share Common Eq
- 19.38
- Period
- 2021
- Cashfrom Operating Activities
- 27.15
- Cashfrom Investing Activities
- -100.39
- Cashfrom Financing Activities
- 72.11
- Net Changein Cash
- -1.14
- Period
- 2020
- Total Revenue
- 235.87
- Selling/ General/ Admin Expenses Total
- 25.92
- Depreciation/ Amortization
- 3.52
- Other Operating Expenses Total
- 43.02
- Total Operating Expense
- 201.26
- Operating Income
- 34.61
- Net Income Before Taxes
- 34.75
- Net Income
- 27.47
- Diluted Normalized EPS
- 3.84
- Period
- 2020
- Total Assets
- 231.89
- Total Liabilities
- 120.08
- Total Equity
- 111.81
- Tangible Book Valueper Share Common Eq
- 12.19
- Period
- 2020
- Cashfrom Operating Activities
- 27.08
- Cashfrom Investing Activities
- -23.94
- Cashfrom Financing Activities
- 0.19
- Net Changein Cash
- 3.33
- Period
- 2025-03-31
- Total Revenue
- 308.48
- Selling/ General/ Admin Expenses Total
- 23.3
- Depreciation/ Amortization
- 7.3
- Other Operating Expenses Total
- 37.74
- Total Operating Expense
- 230.82
- Operating Income
- 77.66
- Net Income Before Taxes
- 82.83
- Net Income
- 62.48
- Diluted Normalized EPS
- 7.8
- Period
- 2025-03-31
- Total Assets
- 1549.26
- Total Liabilities
- 239.63
- Total Equity
- 1309.63
- Tangible Book Valueper Share Common Eq
- 152.02
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 118.34
- Cashfrom Investing Activities
- -223.94
- Cashfrom Financing Activities
- 261.12
- Net Changein Cash
- 155.52
- Period
- 2024-12-31
- Total Revenue
- 274.99
- Selling/ General/ Admin Expenses Total
- 21.67
- Depreciation/ Amortization
- 6.32
- Other Operating Expenses Total
- 36.84
- Total Operating Expense
- 212.64
- Operating Income
- 62.35
- Net Income Before Taxes
- 63.33
- Net Income
- 44.95
- Diluted Normalized EPS
- 5.68
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 246.73
- Selling/ General/ Admin Expenses Total
- 19.63
- Depreciation/ Amortization
- 6.83
- Other Operating Expenses Total
- 38.62
- Total Operating Expense
- 204.63
- Operating Income
- 42.11
- Net Income Before Taxes
- 50.04
- Net Income
- 37.33
- Diluted Normalized EPS
- 4.69
- Period
- 2024-09-30
- Total Assets
- 1426.9
- Total Liabilities
- 224.81
- Total Equity
- 1202.09
- Tangible Book Valueper Share Common Eq
- 138.79
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 46.28
- Cashfrom Investing Activities
- -279.18
- Cashfrom Financing Activities
- 261.36
- Net Changein Cash
- 28.46
- Period
- 2024-06-30
- Total Revenue
- 176.67
- Selling/ General/ Admin Expenses Total
- 19.06
- Depreciation/ Amortization
- 6.18
- Other Operating Expenses Total
- 25.76
- Total Operating Expense
- 153.33
- Operating Income
- 23.34
- Net Income Before Taxes
- 19.95
- Net Income
- 13.95
- Diluted Normalized EPS
- 1.84
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 224.96
- Selling/ General/ Admin Expenses Total
- 17.04
- Depreciation/ Amortization
- 4.9
- Other Operating Expenses Total
- 29.75
- Total Operating Expense
- 187.03
- Operating Income
- 37.93
- Net Income Before Taxes
- 37.2
- Net Income
- 25.15
- Diluted Normalized EPS
- 2.04
- Period
- 2024-03-31
- Total Assets
- 1095.9
- Total Liabilities
- 421.91
- Total Equity
- 674
- Tangible Book Valueper Share Common Eq
- 82.28
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 125.17
- Cashfrom Investing Activities
- -365.39
- Cashfrom Financing Activities
- 239.36
- Net Changein Cash
- -0.83
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Acutaas Chemicals Technical
Moving Average
SMA
- 5 Day1124.75
- 10 Day1141.29
- 20 Day1155.2
- 50 Day1153.09
- 100 Day1141.65
- 300 Day1023.94
Acutaas Chemicals Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Alkyl Amines Chemicals
- 1996.85
- -20.6
- -1.02
- 2497.95
- 1509.2
- 10248.26
- Sudarshan Chemicals Industries
- 1252
- -1.4
- -0.11
- 1312.45
- 782.4
- 9837.33
- Acutaas Chemicals
- 1100.25
- -4.2
- -0.38
- 1321.75
- 600
- 9007.63
- Rashtriya Chemicals And Fertil
- 159
- -4.9
- -2.99
- 245
- 108.05
- 8771.84
- Privi Speciality Chemicals
- 2357
- 95.1
- 4.2
- 2580
- 1138.7
- 9176.03
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Alkyl Amines Chemicals
- 55.26
- 7.34
- 20.89
- 14.49
- Sudarshan Chemicals Industries
- 78.58
- 7.61
- 21.18
- 7.71
- Acutaas Chemicals
- 56.7
- 7.02
- 15.4
- 13.08
- Rashtriya Chemicals And Fertil
- 37.7
- 1.9
- 12.33
- 3.29
- Privi Speciality Chemicals
- 47.85
- 8.11
- 12.5
- 6.33
Acutaas Chemicals Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 02-May-25
- Audited Results & Final Dividend
- 21-Feb-25
- Stock Split
- 28-Jan-25
- Quarterly Results
- 29-Oct-24
- Quarterly Results
- 12-Aug-24
- Quarterly Results
- 10-May-24
- Audited Results & Final Dividend
- 26-Apr-24
- Preferential issue of shares
- 12-Apr-24
- Others
- 12-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 10-May-25
- 17-Apr-25
- EGM
- 28-Mar-25
- 24-Feb-25
- POM
- 20-Sept-24
- 02-Sept-24
- AGM
- 25-Sept-23
- 05-Sept-23
- AGM
- 06-Sept-23
- 07-Aug-23
- POM
- 30-Apr-22
- 28-Mar-22
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 02-May-25
- -
- -
- 1.5
- 10-May-24
- 13-Sept-24
- 13-Sept-24
- 3
- 15-May-23
- 18-Sept-23
- 18-Sept-23
- 3
- 16-May-22
- 01-Aug-22
- 29-Jul-22
- 3

- Ex-Splits
- Old FV
- New FV
- Description
- 25-Apr-25
- 10
- 5
- Stock split from Rs. 10/- to Rs. 5/-/
